SCHEMBL225199

SCHEMBL225199

C=CCC1(CC(=O)O)CCCCC1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
CYP1A2 P05177 2/20 0.57
USP2 O75604 2/20 0.57
LMNA P02545 1/20 0.57
TSHR P16473 1/20 0.57
BLM P54132 1/20 0.57
CACNA2D1 P54289 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
CYP2C19 P33261 1/20 0.45
MAPK1 P28482 1/20 0.41
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
HSD11B1 P28845 1/20 0.38
HPGD P15428 1/20 0.37
GAA P10253 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14390606 0.98 ALDH1A1 (0.53) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL2043119 0.90 CYP1A2 (0.42) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL6577662 0.82 ALDH1A1 (0.59) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL203062 0.81 ALDH1A1 (0.40) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL2871721 0.80 ALDH1A1 (0.74) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL3421776 0.80 ALDH1A1 (0.74) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL98282 0.80 ALDH1A1 (0.74) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL10602483 0.80 ALDH1A1 (0.74) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL8666421 0.79 ALDH1A1 (0.37) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL5076582 0.79 ALDH1A1 (0.55) ALDH1A1CYP1A2USP2LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250302014-A1 WASP PEST MANAGEMENT SYSTEM TONER DARADH (IE) 2025-10-02 US disclosed
EP-4518647-A1 WASP PEST MANAGEMENT SYSTEM Toner, Daradh (IE) 2025-03-12 EP disclosed
US-12042365-B2 Fluid-absorbent article BASF SE (DE) 2024-07-23 US disclosed
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 US disclosed
US-11911249-B2 Fluid-absorbent article BASF SE (DE) 2024-02-27 US disclosed
WO-2023214095-A1 WASP PEST MANAGEMENT SYSTEM TONER DARADH (IE) 2023-11-09 WO disclosed
EP-3416729-B1 PRO-FRAGRANCE COMPOSITION AQDOT LTD (GB) 2023-09-20 EP disclosed
US-11758933-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2023-09-19 US disclosed
CN-112638337-B Feminine hygiene absorbent article 巴斯夫欧洲公司 2023-01-20 CN disclosed
EP-3576701-B1 FLUID-ABSORBENT ARTICLE BASF SE (DE) 2022-10-19 EP disclosed
WO-2003028778-A2 POLYMER MIXTURE OF HYDROGELS WITH DIFFERENT PH VALUE BASF AKTIENGESELLSCHAFT (DE) 2003-04-10 WO disclosed
EP-1294671-A2 UTILISATION OF KETONES AS PRECURSORS OF ACTIVE COMPOUNDS FIRMENICH SA (CH) 2003-03-26 EP disclosed
WO-2003002623-A1 ACIDIC HYDROGELS WHICH ARE CAPABLE OF SWELLING BASF AKTIENGESELLSCHAFT (DE) 2003-01-09 WO disclosed
WO-2002094329-A1 ODOR CONTROL CONTAINING ABSORBENT MATERIALS BASF AKTIENGESELLSCHAFT (DE) 2002-11-28 WO disclosed
WO-2001096272-A2 UTILISATION OF KETONES AS PRECURSORS OF ACTIVE COMPOUNDS FIRMENICH SA (CH) 2001-12-20 WO disclosed
EP-0988025-A1 PERFUMED COMPOSITIONS AND METHODS FOR REDUCING BODY ODORS AND EXCESS MOISTURE THE PROCTER & GAMBLE COMPANY (US) 2000-03-29 EP disclosed
US-5861144-A UNCOMPLEXED CYCLODEXTRIN, PERFUME, MOISTURE ABSORBER, POWDER CARRIER THE PROCTER & GAMBLE COMPANY (US) 1999-01-19 US disclosed
US-5861146-A APPLYING MIXTURES CONTAINING UNCOMPLEXED CYCLODEXTRINS, PERFUMES(BOTH FREE AND ENCAPSULATED), ADJUVANTS AND POWDERED CARRIERS TO SKIN THE PROCTER & GAMBLE COMPANY (US) 1999-01-19 US disclosed
US-5861143-A DRYING AND DEODORIZING SKIN WITH CYCLODEXTRIN AND PERFUMES THE PROCTER & GAMBLE COMPANY (US) 1999-01-19 US disclosed
WO-1998056340-A1 PERFUMED COMPOSITIONS AND METHODS FOR REDUCING BODY ODORS AND EXCESS MOISTURE THE PROCTER & GAMBLE COMPANY (US) 1998-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108040-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 ALDH1A1 978/4885CYP1A2 4564/4885USP2 4693/4885
US-11758933-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 ALDH1A1 978/4885CYP1A2 4564/4885USP2 4693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.